Navigation Links
Brooke Franchise Corporation Announces Selected July Results
Date:8/31/2007

OVERLAND PARK, Kan., Aug. 31 /PRNewswire-FirstCall/ -- Brooke Franchise Corporation, a subsidiary of Brooke Corporation (Nasdaq: BXXX), announced selected July 2007 results.

Brooke Franchise Corporation assisted franchisees in the start up and acquisition of businesses in July in the states of Arizona, California, Georgia, Kansas, Missouri, North Carolina and Texas. Brooke Franchise Corporation added eight start up franchise locations and two developed franchise locations in July, and received approximately $1,673,000 in fees, consisting of $1,650,000 in initial franchise fees for basic services and $23,000 in other associated fees.

Brooke Franchise Corporation received profit-sharing commissions totaling approximately $58,000 from insurance companies in July 2007. Brooke Franchise typically receives a majority of its profit-sharing commissions during the first quarter of its fiscal year.

Combined same-store sales for seasoned converted franchises and start up franchises decreased approximately 0.4 percent for the 12 months ending July 31, 2007, and the corresponding median growth rate was 0.7 percent. Same-store sales calculations exclude profit-sharing commissions.

About our company ... Brooke Franchise Corporation is a subsidiary of Brooke Corporation (Nasdaq: BXXX) that distributes insurance and banking services through a network of more than 800 franchise locations. Brooke Franchise was named the country's No. 37 top franchise by Entrepreneur magaz
'/>"/>

SOURCE Brooke Franchise Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Chiron Corporation Gets US Contract To Produce Bird Flu Vaccines
2. PM announces a new health care order for India
3. PowderMed Announces Needle-Less Flu Vaccine
4. Ramdoss Announces Introduction of RCH-II
5. Britain Announces Third Transfusion Related Mad Cow Case
6. Tibet Announces the Dalai Lama’s Tour of South Americ
7. NHS announces further Cost cutting Measures
8. Indian PM Announces Of Setting Up India Study Center At Tashkent
9. Malaysia Announces Prison term On People Donating HIV-Contaminated Blood
10. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
11. Australian Government Announces Survey To Tackle Childhood Obesity

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...l, November 20 Cardio Va....CVSLMEDICAL.COM , a leading,developer of advanced...d that,the company,s Board of Directors has decide...a and the Far East for its proprietary next-genera...oplasty (PCTA) procedures. , Cardio Vascu...
(Date:11/20/2009)...o formaldehyde used for embalming in the funeral i...death from myeloid leukemia, according to a new st...f the National Cancer Institute . , Previous stu...poietic malignancies and brain cancer in anatomist... of whom may have worked with formaldehyde. , ...
(Date:11/20/2009)... buying 90-day supply, study finds , , F...month supply of prescription drugs is up to one-th...ing to a new study. , U.S. researchers analyzed... 2000 and 2005, and found that patients who bought...y saved an average 29 percent in out-of-pocket cos...
(Date:11/20/2009)...ov. 20 Missouri state employees in...will now have the option to choose Mercy Health Pl... Missouri Consolidated Health Care Plan (MCHCP) an...h Central Missouri regions include the following c...llas, Douglas, Greene, Hickory, Howell, Jasper, La...
(Date:11/20/2009)... The Senate,s newly rel...Affordable Care Act") infringes on Americans, heal... Blevins, president of the Institute for Health Fr...ton, D.C. ,, The bill would (among many other ...ident to buy government-sanctioned health insuranc...
Breaking Medicine News(10 mins):Health News:Cardio Vascular Medical Device to Apply for Additional Patents in Europe, Canada and Far East 2Health News:Funeral industry workers exposed to formaldehyde face higher risk of leukemia 2Health News:Three-Month Supply Lowers Drug Costs 2Health News:Missouri Consolidated Health Care Plan Provides Mercy Health Plans Option 2Health News:Senate Mandatory Health-Insurance Bill Infringes on Choice and Privacy 2
...h, scientists have successfully converted human em...ope that in future, replacement cartilage could be...s and medical // problems, including sports injuri...rnal Tissue Engineering, involved growing human em...
...s are developing tests that can identify the begin...l signs of the disease emerge. The researche...at the annual meeting of the Society for Neuroscie... study groups, doctors could start using the tests...
...hat replaces some carbohydrates with either protei...blood pressure and cholesterol levels, resulting i... disease, // according to government-funded studie...otein-rich food, mostly from plant sources, or to ...
...t heart disease is ranked as the first most common... test called dobutamine stress echocardiography th...s in women. // The study has been conducted ...that can be categorized into two- traditional and ...
...be now detected by using a hand-held scope called ...Agency from the fund given by National Institute o... blue light that // is better than the conventiona... is achieved when oral cancer is treated in its ea...
...is patients in Britain can look forward to some re...vailable to them for the first time, following app...m Canada. // Patients in Britain will soon b...s yet to be licensed in the UK. The Home Office ha...
Other Medicine News:Health News:Another Potential Of Stem Cells Discovered: Used For Growing Cartilage 2Health News:Diagnosis of Alzheimer's years before clinical signs emerge 2Health News:A new study by John Hopkins University proposes formula for good health 2Health News:A new study by John Hopkins University proposes formula for good health 3Health News:A Simple Test To Detect Heart Disease In Women Can Be Lifesaving 2Health News:Relief For British MS Patients: Cannabis-Based Oral Spray 2
(Date:11/20/2009)...Newswire-FirstCall/ -- Smith & Nephew ( SNN, L...ce the signing of a technology development contrac...t may lead to the creation of a fracture fixation ...the limbs of soldiers who sustain battlefield inju...ch Projects Agency (DARPA), the central research a...
(Date:11/19/2009)... BioCryst Pharmaceuticals...g of a public offering of 5,000,000 shares of its ...s proceeds of $48.75 million. All of the shares a...ive shelf registration statement previously filed ...ryst has also granted the underwriters a 30-day op...
(Date:11/19/2009)...9 /PRNewswire-Asia/ -- ScinoPharm, a leading globa...PIs), announced that its,Tainan facility has recei...SafeBridge(R) Consultants, Inc. The Certification ...n the safe handling of potent active,pharmaceutica...ratories and,production areas used for the manufac...
Breaking Medicine Technology:Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 2Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 3Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 4BioCryst Announces Pricing of Public Offering of Common Stock 2BioCryst Announces Pricing of Public Offering of Common Stock 3ScinoPharm Announces SafeBridge Potent Compound Safety Certification 2CQ Forum on Biosimilar Biological Products Wed June 17 2009 12618 1Proteolix Inc Drug Candidate PR 957 Prevents Disease Progression in Rheumatoid Arthritis Models by Selective Inhibition of the Immunoproteasome 4591 1Proteolix Inc Drug Candidate PR 957 Prevents Disease Progression in Rheumatoid Arthritis Models by Selective Inhibition of the Immunoproteasome 4591 2Proteolix Inc Drug Candidate PR 957 Prevents Disease Progression in Rheumatoid Arthritis Models by Selective Inhibition of the Immunoproteasome 4591 3Coming Soon 3A Lung Cancer Spray 3F 48863 1Coming Soon 3A Lung Cancer Spray 3F 48863 2
...in Long-term PASI 75, Response and Marked Improve... Study Findings, BUENOS AI...s from an international, Phase 3 study showed that... severe plaque psoriasis receiving,two doses of us...nt,reduction in psoriasis at week 12, the primary ...
...es, Inc. (Nasdaq: RMTI ), a leading, innovative m...ialty pharmaceuticals focused on the end-,stage-re... has begun dosing,patients in its Phase IIb Dose-R...hate (SFP), the Company,s physiological iron-maint...n is a double-blind, multi-center,randomized, plac...
Other Medicine Technology:Promising Phase 3 Trial Results Show Novel Biologic Therapy Ustekinumab (CNTO 1275) Significantly Improved Psoriasis 2Promising Phase 3 Trial Results Show Novel Biologic Therapy Ustekinumab (CNTO 1275) Significantly Improved Psoriasis 3Promising Phase 3 Trial Results Show Novel Biologic Therapy Ustekinumab (CNTO 1275) Significantly Improved Psoriasis 4Promising Phase 3 Trial Results Show Novel Biologic Therapy Ustekinumab (CNTO 1275) Significantly Improved Psoriasis 5Promising Phase 3 Trial Results Show Novel Biologic Therapy Ustekinumab (CNTO 1275) Significantly Improved Psoriasis 6Rockwell Medical Technologies, Inc. Begins Dosing Patients for SFP Phase IIb Clinical Study 2Rockwell Medical Technologies, Inc. Begins Dosing Patients for SFP Phase IIb Clinical Study 3Rockwell Medical Technologies, Inc. Begins Dosing Patients for SFP Phase IIb Clinical Study 4
VACUETTE® Tube Holders
Safety Phlebotomy PROGUARD II Safety Needle Holder
Optima III 45 Noninsulated Duck-Bill Grasper, without ratchet
Optima III Noninsulated Stabilizing Grasper, with ratchet
Medicine Products: